Evidence map›Paper›PMID 27399214›Full record

ArticleCell cycle (Georgetown, Tex.)2016

New insights into the regulation by RUNX1 and GFI1(s) proteins of the endothelial to hematopoietic transition generating primordial hematopoietic cells.

Roshana Thambyrajah, Rahima Patel, Milena Mazan, Michael Lie-A-Ling, Andrew Lilly, Alexia Eliades, Sara Menegatti, Eva Garcia-Alegria, Magdalena Florkowska, Kiran Batta and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Endothelial Cell Differentiation and Hemogenic Specification.Cold Spring Harbor perspectives in medicine · 2022
    Review
  4. Review
  5. Human yolk sac-like haematopoiesis generatesDevelopment (Cambridge, England) · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Roshana Thambyrajaha CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Rahima Patela CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Milena Mazana CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Michael Lie-A-Linga CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Andrew Lillyb CRUK Stem Cell Haematopoiesis, Cancer Research UK Manchester Institute , Manchester , UK.
Alexia Eliadesb CRUK Stem Cell Haematopoiesis, Cancer Research UK Manchester Institute , Manchester , UK.
Sara Menegattib CRUK Stem Cell Haematopoiesis, Cancer Research UK Manchester Institute , Manchester , UK.
Eva Garcia-Alegriab CRUK Stem Cell Haematopoiesis, Cancer Research UK Manchester Institute , Manchester , UK.
Magdalena Florkowskaa CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Kiran Battaa CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Valerie Kouskoffb CRUK Stem Cell Haematopoiesis, Cancer Research UK Manchester Institute , Manchester , UK.
Georges Lacauda CRUK Stem Cell Biology, Cancer Research UK Manchester Institute , Manchester , UK.
Cancer Research UK Manchester Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I001794/1Cancer Research UK 12486Cancer Research UK 19565
6 · The paper itself

Abstract

The first hematopoietic cells are generated very early in ontogeny to support the growth of the embryo and to provide the foundation to the adult hematopoietic system. There is a considerable therapeutic interest in understanding how these first blood cells are generated in order to try to reproduce this process in vitro. This would allow generating blood products, or hematopoietic cell populations from embryonic stem (ES) cells, induced pluripotent stem cells or through directed reprogramming. Recent studies have clearly established that the first hematopoietic cells originate from a hemogenic endothelium (HE) through an endothelial to hematopoietic transition (EHT). The molecular mechanisms underlining this transition remain largely unknown with the exception that the transcription factor RUNX1 is critical for this process. In this Extra Views report, we discuss our recent studies demonstrating that the transcriptional repressors GFI1 and GFI1B have a critical role in the EHT. We established that these RUNX1 transcriptional targets are actively implicated in the downregulation of the endothelial program and the loss of endothelial identity during the formation of the first blood cells. In addition, our results suggest that GFI1 expression provides an ideal novel marker to identify, isolate and study the HE cell population.

Indexed as

HematopoiesisAnimalsCore Binding Factor Alpha 2 SubunitHemangioblastsHematopoietic Stem CellsModels, BiologicalTranscription FactorsCore Binding Factor Alpha 2 SubunitTranscription FactorsdevelopmentEHT (endothelial to hematopoietic transition)ES cellsGFI1GFI1Bhematopoiesishemogenic endotheliumHSCs (Hematopoietic stem cells)reprogrammingRUNX1

Identifiers

PMID27399214
PMCPMC4993433
OpenAlexW2463002880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.